Catalyst Wire Dossier Catalyst Wire Dossier

Nevanimibe HCl

nevanimibe hydrochloride · Millendo Therapeutics US, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nevanimibe HCl, covering 2021-03-04 to 2021-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Nevanimibe HCl for the Treatment of Classic CAH [Phase 2]

See pricing